Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

MINOCA

ClinicalTrials.gov lists 29 trials for MINOCA or a narrower condition beneath it.

MeSH D000088442 Cardiovascular Diseases C14 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 1 Phase 4 Phase 4 2 Not applicable Not applicable 6 Observational Observational 20 Phase 2 Phase 2 1 Phase 4 Phase 4 2 Not applicable Not applicable 6 Observational Observational 20

Trials per phase (log scale)

29 of the 29 trials are tagged with MINOCA itself; the rest are tagged with a narrower condition beneath it.

Get the MINOCA report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did MINOCA trials start? (9)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 5

2017: 2 trials (Observational 2) 2018: 4 trials (Observational 2, Not applicable 1, Phase 4 1) 2019: 3 trials (Observational 2, Not applicable 1) 2020: 1 trials (Observational 1) 2021: 3 trials (Observational 2, Phase 4 1) 2022: 4 trials (Observational 2, Not applicable 1, Phase 2 1) 2023: 5 trials (Observational 3, Not applicable 2) 2024: 3 trials (Observational 3) 2025: 4 trials (Observational 3, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 4
2024 3
2023 5
2022 4
2021 3
2020 1
2019 3
2018 4
2017 2

No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are MINOCA trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 1
Phase 4 2
Not applicable 6
Observational 20

How many MINOCA trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 12
Active, not recruiting 1
Completed 5
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for MINOCA? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Anticoagulant 1

Interventions as named in the registry (13)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Beta Blocker 2
Statin 1
data collection 1
ARB 1
Antiplatelet Drug 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover MINOCA? (14)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages